Fundraising Fox

Vensun Pharmaceuticals

Yardley, US · Founded 2012 · Delaware corporation

Biotech

Founders & leadership

HP
Hemanshu PandyaPresident, Chief Executive Officer and Director of Issuer
SE
Syed E. AbidiNamed on SEC filing

Board

DG
Dhananjay G. WadekarBoard director
JW
Jason WildBoard director
ES
Edward SchutterBoard director
KH
Kamlesh HaribhaktiBoard director

Reported raises · per SEC filings

Form D private placements

$29.2M disclosed across 3 rounds · 2012–2016

▶$19.5MraisedDec 2016 · 10 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Kamlesh HaribhaktiDirector
  • Syed E. AbidiDirector
  • Michael AltmanDirector
  • Hemanshu PandyaExecutive Officer, Director
  • Jason WildDirector
  • Edward SchutterDirector
  • Dhananjay G. WadekarDirector
Offering amount
$22.5M
Amount sold
$19.5M
Sales commissions
$995K
Proceeds to insiders
$9K
Placement agents
Leerink Partners LLC
First sale
Nov 2016
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedOct 2015 · 15 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Edward SchutterDirector
  • Dhananjay G. WadekarDirector
  • Jason WildDirector
  • Kamlesh HaribhaktiDirector
  • Syed E. AbidiDirector
  • Hemanshu PandyaExecutive Officer, Director
Offering amount
$16M
Amount sold
$4M
First sale
Sep 2015
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.7MraisedMar 2012 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Dhananjay G. WadekarDirector
  • Kamlesh HaribhaktiDirector
  • Jason WildDirector
  • Hemanshu PandyaExecutive Officer, Director
  • Syed E. AbidiDirector
Offering amount
$5.7M
Amount sold
$5.7M
First sale
Mar 2012
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Vensun Pharmaceuticals, Inc. Completes Series C Financing | Business Wirebusinesswire.com · Dec 2016Vensun Pharmaceuticals Completes Series C Financing - BioSpacebiospace.com · Dec 2016Vensun Pharmaceuticals, Inc. Rounds Up $15.8 Million Series B Financing Round - BioSpacebiospace.com · Dec 2013Vensun Pharmaceuticals - Tech Company Profile - Gaebler.com Venture Capital Databasegaebler.com

Frequently asked questions

How much funding has Vensun Pharmaceuticals raised?
Vensun Pharmaceuticals has disclosed $29.2M raised across 3 rounds.
Where is Vensun Pharmaceuticals headquartered?
Vensun Pharmaceuticals is headquartered in Yardley, US.